The Italian pharmaceutical group Stevanato, through its subsidiary Ompi do Brasil, which owns a production plant in Sete Lagoas, in the State of Minas Gerais, has won a €2 million contract for the production, in 2022, of 46 million glass vials (4ml) for the Covid vaccine from Fiocruz (Astrazeneca), a scientific institution linked to the Brazilian Ministry of Health.
Stevanato Group, which is headquartered in Piombino Dese (Padua), will start delivering the new vials from February 2022. In order to meet this commitment, two additional production lines of the Covid vaccine vials will be delivered from Italy in 2022, which will step up production by 50%.
Back in March, Ompi do Brasil had won a €1.1 million contract to supply 22 million glass vials (4ml) by the end of 2021, on behalf of Fiocruz.
